ProfileGDS4459 / ENSG00000151623
TitleIntraportal tacrolimus flushing effect on liver allograft
OrganismHomo sapiens


flushed with tacrolimus flushed with albumin control GSM623464 GSM623465 GSM623466 GSM623467 GSM623468 GSM623469 GSM623470 GSM623471 GSM623472 GSM623473 GSM623474 GSM623475 GSM623476 GSM623477 GSM623478 GSM623479 GSM623480 54% 55% 69% 48% 72% 54% 45% 68% 68% 61% 69% 62% 69% 36% 65% 60% 57% sort by protocol Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM623464group A, liver allograft wedge biopsie tacrolimus treatment 14.5554
GSM623465group A, liver allograft wedge biopsie tacrolimus treatment 24.5755
GSM623466group A, liver allograft wedge biopsie tacrolimus treatment 35.369
GSM623467group A, liver allograft wedge biopsie tacrolimus treatment 44.4348
GSM623468group A, liver allograft wedge biopsie tacrolimus treatment 55.4772
GSM623469group A, liver allograft wedge biopsie tacrolimus treatment 64.5554
GSM623470group A, liver allograft wedge biopsie tacrolimus treatment 74.2445
GSM623471group A, liver allograft wedge biopsie tacrolimus treatment 85.2668
GSM623472group A, liver allograft wedge biopsie tacrolimus treatment 95.2868
GSM623473group A, liver allograft wedge biopsie tacrolimus treatment 104.961
GSM623474group B, liver allograft wedge biopsie placebo treatment 15.1869
GSM623475group B, liver allograft wedge biopsie placebo treatment 24.8962
GSM623476group B, liver allograft wedge biopsie placebo treatment 35.2969
GSM623477group B, liver allograft wedge biopsie placebo treatment 43.9736
GSM623478group B, liver allograft wedge biopsie placebo treatment 55.0765
GSM623479group B, liver allograft wedge biopsie placebo treatment 64.7460
GSM623480group B, liver allograft wedge biopsie placebo treatment 74.6257